Ant Uzay
Acıbadem University
22 Papers
65 Citations
Ant Uzay is an academic researcher from Acıbadem University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 8 publications.
Chat about Author
Papers
Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature
TL;DR: An 89‐year‐old human immunodeficiency virus (HIV)‐negative male patient with HHV8‐unrelated PEL‐like lymphoma in the pleura is described, which seems to be better than HIV‐ and HHV‐8‐positive PEL.
66
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Olga Meltem Akay,Murat Ozbalak,Mustafa Pehlivan,Birol Yildiz,Ant Uzay,Tuğçe Nur Yiğenoğlu,Tugrul Elverdi,Leylagül Kaynar,Orhan Ayyildiz,İpek Yönal Hindilerden,Hasan Sami Goksoy,Sebnem Izmir Guner,Ahmet Kursad Gunes,Mehmet Sönmez,Meltem Kurt Yuksel,Sinem Civriz Bozdag,Zübeyde Nur Özkurt,Tayfur Toptas,Mehmet Hilmi Dogu,Ozan Salim,Güray Saydam,Irfan Yavasoglu,Meltem Ayli,Gülsüm Özet,Murat Albayrak,Elif Birtas Atesoglu,Selami Kocak Toprak,Rahsan Yildirim,Özgür Mehtap,Sevgi Kalayoglu Besisik,Meliha Nalcaci,Fevzi Altuntaş,Burhan Ferhanoglu +32 more
TL;DR: The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT).
12
Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature.
Bulent Kantarcioglu,Isik Kaygusuz-Atagunduz,Ant Uzay,Tayfur Toptas,Tulin Firatli Tuglular,Mahmut Bayik +5 more
TL;DR: A t(9;22)(p24;q11.2) translocation of JAK2 is reported, in a MDS patient and results associated with BCR-JAK2 fusion reported in the literature are reviewed.
11
The prognostic value of CD49d expression in Turkish patients with chronic lymphocytic leukemia
Ant Uzay,Tayfur Toptas,Isik Kaygusuz,Emel Eksioglu Demiralp,Tulin Firatli Tuglular,Mahmut Bayik +5 more
TL;DR: The study’s findings show that the patients with high CD49d expression at the time of diagnosis had more advanced disease and poorer response to therapy; however, their overall survival did not differ from that of the Patients with advanced disease stage, but lower levels of CD 49d expression.
3
Does it take three to tango? An unsuspected multimorbidity of CD8+ T cell lymphoproliferative disorder, malaria, and EBV infection.
Suheyla Ekemen,Ant Uzay,Nuray Bassullu,Emel Dikicioglu-Cetin,Kyoko Matsuda,Umit Ince,Cevayir Coban +6 more
TL;DR: This case emphasizes the clinical importance of EBV monitoring in T-LGL patients with skin involvement and indicates that Plasmodium infection should be examined in patients from malaria endemic regions by pathological and molecular investigations.